Luke O’Neill

Chair of Biochemistry
Trinity College, Dublin

Professor Luke O’Neill holds the Chair of Biochemistry at Trinity College Dublin where he leads the Inflammation Research Group. He has a PhD in Pharmacology from the University of London and carried out Post-Doctoral research at Cambridge U.K. His research is in the area of the molecular basis to inflammatory diseases. In 2017 he was named by Thompson Reuters as one of the world’s most influential scientists, being in the top 1% in Immunology. He is co-founder of 2 Spin-out companies - Opsona Therapeuticsand Inflazome, which is developing new treatments for inflammatory diseases. He was elected a Fellow of the Royal Society in 2016.